Hermes Biosciences

High-Yield exosome isolation

Business Model
B2B
Total Funding
$6.0M
Last Round
$6.0M SeedNov 2025
Rounds
1

About

The Hermes Biosciences team brings decades of experience building and scaling innovative biotech tools, with a strong track record of launching impactful life sciences and diagnostics products. By combining deep molecular biology insight with engineering innovation, the team is developing a next-generation extracellular vesicle isolation solution to accelerate discovery for researchers. The technology captures the biological units of communication between cells at higher yield and quality, increasing their value in understanding, diagnosing, and treating cancer, degenerative diseases, and conditions in regenerative medicine.

Summary

Hermes Biosciences is a Biotech company. It has raised $6.0M in total across 1 round, most recently a $6.0M Seed round in Nov 2025. Investors include Genoa Ventures, Paladin Capital Group and Vertical Venture Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedNov 2025
$6.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hermes Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/hermes-biosciences"><img src="https://indexed.vc/api/badge/company/hermes-biosciences" alt="Hermes Biosciences on Indexed.vc" width="260" height="76" /></a>